CTSA Program Funding Information

The CTSA Program provides critical resources and support needed to strengthen the entire spectrum of our nation’s clinical and translational research enterprise. CTSA Program hubs provide core resources, essential mentoring and training, and opportunities to develop innovative approaches and technologies designed to re-engineer existing capabilities. Program support also fosters collaborations to improve the quality, safety, efficiency and speed of clinical and translational research.

Funded Activities Under the CTSA Program

View a table of funded activities (PDF, 139KB) under the CTSA Program.

Current Funding Announcements

NCATS has released the following funding opportunity announcements for CTSA Program hub awards, Trial Innovation Centers, Recruitment Innovation Centers and Collaborative Innovation Awards.

Clinical and Translational Science Awards

  • NOT-TR-20-007: Notice of Special Interest: Research through NCATS’ Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Awards (U01 and R21)
  • NOT-OD-20-022: Notice of Special Interest (NOSI): Administrative Supplements to NCATS CTSA Program KL2 Institutional Career Development Awards as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project
  • NOT-TR-19-015: Notice of Information: NCATS Clinical and Translational Science Awards (CTSA) Programs Interest in Improving Rural Health Outcomes and Eliminating Health Disparities
  • PAR-18-940: Clinical and Translational Science Award (U54 Clinical Trial Optional)
    • NOT-TR-19-014: Notice of Change to PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
      • NOT-TR-19-026: Notice of Change to NOT-TR-19-014: Notice of Change to PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
    • NOT-TR-19-013: Notice of Change to PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
    • NOT-TR-19-010: Notice of Change to PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
    • CTSA Program PAR-18-940 Application Information

Collaborative Innovation Awards

  • PAR-19-099: Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional)
    • NOT-TR-20-004: Notice of Change to Award Budget and Removal of Prior Approval Requirement for PAR-19-099, Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional)
    • NOT-TR-19-023: Notice of Change to PAR-19-099 Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional)
    • NOT-TR-19-016: Notice of Change to FOA PAR-19-099: Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional)
  • PAR-19-100: Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)
    • NOT-TR-19-024: Notice of Change to PAR-19-100 Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (R21 Clinical Trial Optional)
    • NOT-TR-19-017Notice of Change to FOA PAR-19-100: Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)
  • Collaborative Innovation Frequently Asked Questions

Competitive Revision Awards

  • PAR-19-337Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional)

Administrative Supplements

  • PA-18-906Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
    • NOT-OD-18-226Additional Awards Eligible for PA-18-906 “Research Supplements to Promote Diversity in Health-Related Research” (Admin Supp)
  • PA-18-592Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed)
  • PA-18-591Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
    • NOT-OD-20-022: Notice of Special Interest (NOSI): Administrative Supplements to NCATS CTSA Program KL2 Institutional Career Development Awards as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down Syndrome)
    • NOT-OD-20-024: Notice of Special Interest (NOSI): Availability of Administrative Supplements for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down Syndrome) Project
    • NOT-HL-19-724: Notice of Special Interest (NOSI): Availability of Administrative and Revision Supplements to Expand Vaping Research and Understand EVALI

Conference Grants

View all of NCATS’ current funding opportunities.

Expired Funding Announcements

Visit the expired CTSA Program funding announcements page to learn more about past CTSA Program funding opportunities.